Global Tuberculosis Diagnostics and Treatment Market Size, Status and Forecast 2024-2031

Report ID: 917547 | Published Date: Sep 2024 | No. of Page: 123 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Skin Testing
        1.2.3 Laboratory Testing
    1.3 Market by Application
        1.3.1 Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Tuberculosis Diagnostics and Treatment Market Perspective (2016-2027)
    2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Regions
        2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Tuberculosis Diagnostics and Treatment Industry Dynamic
        2.3.1 Tuberculosis Diagnostics and Treatment Market Trends
        2.3.2 Tuberculosis Diagnostics and Treatment Market Drivers
        2.3.3 Tuberculosis Diagnostics and Treatment Market Challenges
        2.3.4 Tuberculosis Diagnostics and Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue
        3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2016-2021)
        3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
    3.4 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio
        3.4.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 2020
    3.5 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
    3.6 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
    3.7 Date of Enter into Tuberculosis Diagnostics and Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis Diagnostics and Treatment Breakdown Data by Type
    4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2022-2027)

5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application
    5.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
    6.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type
        6.2.1 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
        6.2.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
        6.2.3 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
    6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application
        6.3.1 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
        6.3.2 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
        6.3.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
    6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Country
        6.4.1 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
        6.4.2 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
    7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type
        7.2.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
    7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application
        7.3.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
    7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Country
        7.4.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type
        8.2.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application
        8.3.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region
        8.4.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
    9.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type
        9.2.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
    9.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application
        9.3.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
    9.4 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country
        9.4.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type
        10.2.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application
        10.3.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country
        10.4.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Cepheid Inc
        11.1.1 Cepheid Inc Company Details
        11.1.2 Cepheid Inc Business Overview
        11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction
        11.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.1.5 Cepheid Inc Recent Development
    11.2 Becton Dickinson
        11.2.1 Becton Dickinson Company Details
        11.2.2 Becton Dickinson Business Overview
        11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction
        11.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.2.5 Becton Dickinson Recent Development
    11.3 Hain LifeSciences
        11.3.1 Hain LifeSciences Company Details
        11.3.2 Hain LifeSciences Business Overview
        11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction
        11.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.3.5 Hain LifeSciences Recent Development
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Details
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction
        11.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.4.5 Abbott Laboratories Recent Development
    11.5 Alere, Inc
        11.5.1 Alere, Inc Company Details
        11.5.2 Alere, Inc Business Overview
        11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction
        11.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.5.5 Alere, Inc Recent Development
    11.6 Roche AG
        11.6.1 Roche AG Company Details
        11.6.2 Roche AG Business Overview
        11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction
        11.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.6.5 Roche AG Recent Development
    11.7 Hologic Corporation
        11.7.1 Hologic Corporation Company Details
        11.7.2 Hologic Corporation Business Overview
        11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction
        11.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.7.5 Hologic Corporation Recent Development
    11.8 bioMerieux
        11.8.1 bioMerieux Company Details
        11.8.2 bioMerieux Business Overview
        11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction
        11.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.8.5 bioMerieux Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction
        11.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.9.5 Sanofi Recent Development
    11.10 QIAGEN
        11.10.1 QIAGEN Company Details
        11.10.2 QIAGEN Business Overview
        11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction
        11.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.10.5 QIAGEN Recent Development
    11.11 Akonni Biosystems, Inc.
        11.11.1 Akonni Biosystems, Inc. Company Details
        11.11.2 Akonni Biosystems, Inc. Business Overview
        11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction
        11.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.11.5 Akonni Biosystems, Inc. Recent Development
    11.12 Epistem Holdings Plc
        11.12.1 Epistem Holdings Plc Company Details
        11.12.2 Epistem Holdings Plc Business Overview
        11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction
        11.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.12.5 Epistem Holdings Plc Recent Development
    11.13 Gen-Probe Inc.
        11.13.1 Gen-Probe Inc. Company Details
        11.13.2 Gen-Probe Inc. Business Overview
        11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction
        11.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.13.5 Gen-Probe Inc. Recent Development
    11.14 EIKEN Chemical
        11.14.1 EIKEN Chemical Company Details
        11.14.2 EIKEN Chemical Business Overview
        11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction
        11.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.14.5 EIKEN Chemical Recent Development
    11.15 Thermo Fisher Scientific, Inc
        11.15.1 Thermo Fisher Scientific, Inc Company Details
        11.15.2 Thermo Fisher Scientific, Inc Business Overview
        11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction
        11.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
        11.15.5 Thermo Fisher Scientific, Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Skin Testing
    Table 3. Key Players of Laboratory Testing
    Table 4. Global Tuberculosis Diagnostics and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2016-2021)
    Table 8. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2022-2027)
    Table 10. Tuberculosis Diagnostics and Treatment Market Trends
    Table 11. Tuberculosis Diagnostics and Treatment Market Drivers
    Table 12. Tuberculosis Diagnostics and Treatment Market Challenges
    Table 13. Tuberculosis Diagnostics and Treatment Market Restraints
    Table 14. Global Tuberculosis Diagnostics and Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Tuberculosis Diagnostics and Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2020)
    Table 17. Ranking of Global Top Tuberculosis Diagnostics and Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Tuberculosis Diagnostics and Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
    Table 21. Date of Enter into Tuberculosis Diagnostics and Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Tuberculosis Diagnostics and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Cepheid Inc Company Details
    Table 62. Cepheid Inc Business Overview
    Table 63. Cepheid Inc Tuberculosis Diagnostics and Treatment Product
    Table 64. Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 65. Cepheid Inc Recent Development
    Table 66. Becton Dickinson Company Details
    Table 67. Becton Dickinson Business Overview
    Table 68. Becton Dickinson Tuberculosis Diagnostics and Treatment Product
    Table 69. Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 70. Becton Dickinson Recent Development
    Table 71. Hain LifeSciences Company Details
    Table 72. Hain LifeSciences Business Overview
    Table 73. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product
    Table 74. Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 75. Hain LifeSciences Recent Development
    Table 76. Abbott Laboratories Company Details
    Table 77. Abbott Laboratories Business Overview
    Table 78. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product
    Table 79. Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 80. Abbott Laboratories Recent Development
    Table 81. Alere, Inc Company Details
    Table 82. Alere, Inc Business Overview
    Table 83. Alere, Inc Tuberculosis Diagnostics and Treatment Product
    Table 84. Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 85. Alere, Inc Recent Development
    Table 86. Roche AG Company Details
    Table 87. Roche AG Business Overview
    Table 88. Roche AG Tuberculosis Diagnostics and Treatment Product
    Table 89. Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 90. Roche AG Recent Development
    Table 91. Hologic Corporation Company Details
    Table 92. Hologic Corporation Business Overview
    Table 93. Hologic Corporation Tuberculosis Diagnostics and Treatment Product
    Table 94. Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 95. Hologic Corporation Recent Development
    Table 96. bioMerieux Company Details
    Table 97. bioMerieux Business Overview
    Table 98. bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 99. bioMerieux Recent Development
    Table 100. Sanofi Company Details
    Table 101. Sanofi Business Overview
    Table 102. Sanofi Tuberculosis Diagnostics and Treatment Product
    Table 103. Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 104. Sanofi Recent Development
    Table 105. QIAGEN Company Details
    Table 106. QIAGEN Business Overview
    Table 107. QIAGEN Tuberculosis Diagnostics and Treatment Product
    Table 108. QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 109. QIAGEN Recent Development
    Table 110. Akonni Biosystems, Inc. Company Details
    Table 111. Akonni Biosystems, Inc. Business Overview
    Table 112. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product
    Table 113. Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 114. Akonni Biosystems, Inc. Recent Development
    Table 115. Epistem Holdings Plc Company Details
    Table 116. Epistem Holdings Plc Business Overview
    Table 117. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product
    Table 118. Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 119. Epistem Holdings Plc Recent Development
    Table 120. Gen-Probe Inc. Company Details
    Table 121. Gen-Probe Inc. Business Overview
    Table 122. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product
    Table 123. Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 124. Gen-Probe Inc. Recent Development
    Table 125. EIKEN Chemical Company Details
    Table 126. EIKEN Chemical Business Overview
    Table 127. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product
    Table 128. EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 129. EIKEN Chemical Recent Development
    Table 130. Thermo Fisher Scientific, Inc Company Details
    Table 131. Thermo Fisher Scientific, Inc Business Overview
    Table 132. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product
    Table 133. Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
    Table 134. Thermo Fisher Scientific, Inc Recent Development
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tuberculosis Diagnostics and Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Skin Testing Features
    Figure 3. Laboratory Testing Features
    Figure 4. Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Other Case Studies
    Figure 8. Tuberculosis Diagnostics and Treatment Report Years Considered
    Figure 9. Global Tuberculosis Diagnostics and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Tuberculosis Diagnostics and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Tuberculosis Diagnostics and Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Tuberculosis Diagnostics and Treatment Market Share by Players in 2020
    Figure 14. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics and Treatment Revenue in 2020
    Figure 16. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
    Figure 20. North America Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
    Figure 21. North America Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
    Figure 22. United States Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Region (2016-2027)
    Figure 38. China Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Cepheid Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 58. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 59. Hain LifeSciences Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 61. Alere, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 62. Roche AG Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 63. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 64. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 65. Sanofi Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 66. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 67. Akonni Biosystems, Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 68. Epistem Holdings Plc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 69. Gen-Probe Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 70. EIKEN Chemical Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 71. Thermo Fisher Scientific, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Frequently Asked Questions
Tuberculosis Diagnostics and Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tuberculosis Diagnostics and Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tuberculosis Diagnostics and Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports